Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 308
Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S, Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d

Activities

Open PHACTS - Exploiting semantically integrated life science data for transporter profiling

Gerhard Ecker
BioMedical Transporters
Conference, Talk or oral contribution
7.8.2017 - 7.8.2017

Leveraging linked open data - from transporter interaction profiling to toxicity prediction and beyond

Gerhard Ecker
11th European Workshop in Drug Design
Seminar/Workshop, Talk or oral contribution
23.5.2017 - 23.5.2017

Innovative Medicines Initiative - From semantic data integration to risk assessment

Gerhard Ecker
253rd ACS National Meeting & Exhibition
Conference, Talk or oral contribution
5.4.2017 - 5.4.2017

Leveraging open data for development of ABC-transporter inhibitors

Gerhard Ecker
Gordon Research Conference on Multi-drug Efflux Systems
Conference, Talk or oral contribution
27.3.2017 - 27.3.2017

Leveraging linked open data - from transporter profiling to toxicity prediction and beyond

Gerhard Ecker
Talk or oral contribution
21.3.2017 - 21.3.2017